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Abstract Electrospinning technique was utilized to
engineer a small-diameter (id = 4 mm) tubular graft.
The tubular graft was made from biocompatible and
biodegradable polymers polycaprolactone (PCL) and
poliglecaprone with 3:1 (PCL:PGC) ratio. Enzymatic
degradation effect on the mechanical properties and
fiber morphology in the presence of lipase enzyme were
observed. Significant changes in tensile strength
(1.86–1.49 MPa) and strain (245–205 %) were noticed
after 1 month in vitro degradation. The fiber breakage
was clearly evident through scanning electron microscopy
(SEM) after 4 weeks in vitro degradation. Then, the graft
was coated with a collagenous protein matrix to impart
bioactivity. Human umbilical vein endothelial cells
(HUVECs) and aortic artery smooth muscle cells
(AoSMCs) attachment on the coated graft were observed
in static condition. Further, HUVECs were seeded on the
lumen surface of the grafts and exposed to laminar shear
stress for 12 h to understand the cell attachment. The
coated graft was aged in PBS solution (pH 7.3) at 37 C
for 1 month to understand the coating stability.
Differential scanning calorimetry (DSC) and Fourier
transform infrared spectroscopy (FTIR) suggested the
erosion of the protein matrix from the coated graft under
in vitro condition.
Keywords Poliglecaprone  Lipase  Electrospinning 
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Introduction
Approximately, 800,000 coronary artery bypass graft
surgeries (CABG) are performed worldwide each year
(Dahl et al. 2011). Alarmingly, one-third of the patients
who undergo the CABG procedure do not have viable
autologous grafts (Wang et al. 2007). Further, there are 202
million people suffering from peripheral artery disease
(PAD), and particularly in the USA *8.5 million Amer-
icans aged C40 years have PAD (Go et al. 2014; Fowkes
et al. 2013). Surgeons have used non-degradable synthetic
polytetrafluoroethylene (PTFE) or Dacron medium- to
large-diameter grafts which provide 10 years of symptom-
free lifestyle; however they have extremely poor perfor-
mance due to thrombotic occlusion and intima hyperplasia
when their diameter is\6 mm (Song et al. 2011; Clowes
et al. 1985). In the pediatric population, non-degradable
prosthetic grafts are unable to match with somatic growth,
resulting in requiring a second or third surgery (Cittadella
et al. 2013). Therefore, there is a desperate need for a
small-diameter (\6 mm) vascular graft which can replace
and or repair the damaged native blood vessel, promote
regeneration of a neo tissue, and completely be bioab-
sorbed in the long run.
Researchers have tried various approaches to engineer
such an ideal vascular graft, for instance, natural scaffolds
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(collagen, elastin, fibrin), self-assembled cell sheets, syn-
thetic scaffolds, and decellularized matrix (allogenic,
xenogenic, heterogenic) (Seifu et al. 2013). However, long
fabrication time, potential transmission of disease, throm-
bus formation, hyperplasia, and immune rejections are
critical issues associated with these approaches (Seifu et al.
2013). Hence, a general movement was started to engineer
coated grafts by combining biodegradable and biocom-
patible synthetic polymers with natural proteins such as
collagen, elastin, and fibrin (Sell et al. 2009). Examples of
biodegradable synthetic polymers used in vascular tissue
engineering applications are poly(lactide acid) PLA,
polycaprolactone (PCL), polyurethanes (PU), polyglycolic
acid (PGA), and polydioxanone (PDO) (Sell et al. 2009;
Boland et al. 2005; Stitzel et al. 2001; Kidoaki et al. 2005;
Lee et al. 2008a). In this approach, a synthetic polymer will
provide mechanical integrity and natural proteins provide
biocompatibility and extracellular matrix (ECM)-mimick-
ing environment for better cell attachment and
proliferation.
To fabricate scaffolds for tissue engineering application,
researchers have explored many techniques such as solvent
casting, phase separation, fiber self-assembly, electrospin-
ning, melt molding, decellularization, gas foaming, and
laser sintering (Song et al. 2011). However, the electro-
spinning technique has gained particular interest due to its
simplicity and versatility. This method is capable of
forming nano–microscale fibers which can mimic the nat-
ural tissue ECM morphology; hence, scaffolds made from
this technique can be utilized for various biomedical ap-
plications such as drug delivery and soft/hard tissue re-
generation (Liu et al. 2013). The electrospun biodegradable
scaffolds have a porous structure to allow cell migration
and infiltration, higher surface area for better cell attach-
ment, and a tunable degradation rate which is necessary to
promote neo-tissue ingrowth (Sell et al. 2010).
A new tubular graft from biocompatible and biodegrad-
able PCL and poliglecaprone (PGC) polymers was fabri-
cated by an electrospinning technique (Patel et al. 2015).
PCL is a semicrystalline polymer which provides a slow
degradation time (*2 years); therefore, it can play a critical
role in tissue engineering application when a scaffold re-
quires a longer time to support the damage tissue and pro-
mote regeneration (Gunatillake and Adhikari 2003). PCL
has great viscoelastic properties, which provide the key
qualities for vascular tissue engineering application (Lee
et al. 2003). De Valence et al. (2012) showed a great
structural integrity for the graft made from PCL in rat ab-
dominal aorta model. Unlike PGA, PLA, and poly-lactide-
co-glycolic acid (PLGA), PCL does not undergo plastic
deformation and failure when exposed to long cyclic strain;
therefore, it can be an excellent and critical component in
vascular graft application (Lu et al. 2008). PGC in the form
of Monocryl monofilament sutures displayed excellent
tensile properties and 20–30 % reduction in strength after
2 weeks in vivo (Bezwada et al. 1995). Complete absorp-
tion of PGC in human body between 90 and 120 days with
slight to minimal tissue reaction has been confirmed (Bez-
wada et al. 1995). Therefore, a blend of PCL and PGC can
provide the required mechanical integrity, and faster PGC
degradation can provide room for neo-tissue formation.
Various biodegradable polymers and natural polymers
were combined to engineer an ideal vascular graft in the
past. He et al. (2009) combined PLLA with PCL and
coated with collagen to create a small-diameter vascular
graft and noticed promising biocompatibility and in vivo
results. Ju et al. (2010) used PCL with collagen to fabricate
a tubular graft and showed endothelial cell (ECs) adhesion
as well as smooth muscle cell (SMCs) infiltration from the
outer surface to the lumen side. Han et al. (2010) co-
electrospun a blend of PLGA, gelatin, and elastin to create
a scaffold for vascular tissue engineering and studied EC
and SMC attachment. Pandis et al. (2010) fabricated a
hyaluronan-based scaffold and examined its in vivo per-
formance in rats. Pankajkshan et al. (2008) coated PCL
scaffold with fibrin to engineer a potential vascular graft
and observed EC lining in 15 and 30 days after cultured.
He et al. (2011) utilized PLLA and PCL with fibrinogen for
potential soft tissue engineering applications as well. In-
terestingly, Wang et al. (2009) combined PLA with silk
fibroin to generate tubular scaffolds and examined me-
chanical as well as biocompatibility with different cell lines
for potential use in blood vessel tissue engineering appli-
cation. Though extraordinary efforts have been undertaken
to solve the critical need for an ideal vascular graft, a
clinically available bio-hybrid tubular graft requires further
research. In our recent publication, we have shown that 3:1
(PCL:PGC) blend had the most desirable mechanical
properties for vascular graft application (Patel et al. 2015).
PCL breaks down by hydrolytic degradation mechanism,
and it has been studied by Pena et al. (2006). However,
there have been studies showing that the hydrolytic
degradation may be catalyzed by enzymes such as lipase
(Zeng et al. 2004; Gan et al. 1999). Lipase, an extracellular
hydrolytic enzyme which is water soluble, is able to digest
aliphatic polyesters such as PCL (Rizzarelli et al. 2004;
Tokiwa and Suzuki 1977). Researchers have incorporated
collagen, elastin, chitosan, hyaluronic acid, fibrin, and ge-
latin to create bioactive scaffold for vascular tissue engi-
neering application (McClure et al. 2009a, b; Pankajakshan
et al. 2008; Yin et al. 2013; He et al. 2005; Antunes et al.
2010; Thomas et al. 2007; Zhang et al. 2009). However, a
blood vessel is composed of three distinct layers which
have different proteins that work synergistically to provide
proper functionality (Stegemann et al. 2007). Hence, it may
be beneficial to incorporate a collagenous matrix which is
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made of different proteins such as various types of collagen
and laminin to closely mimic the structure of a blood
vessel. Hence, to make our graft’s surface bioactive for cell
adhesion, the graft was coated with a collagenous matrix
(Siegal and Singh 2010) by dip coating. Finally, AoSMCs
and HUVECs attachment was studied on the coated graft in
static condition. Further, shear stress plays a crucial role in
the long-term maintenance of blood vessel functionality
(Traub and Berk 1998). Hence, HUVECs attachment was
studied under a dynamic condition.
Materials and methods
Materials
Polycaprolactone (PCL) with inherent viscosity between 1.0
and 1.3 dL/g in CHCl3 was obtained from LACTEL Ab-
sorbable Polymers (Birmingham, AL). Poliglecaprone
(PGC) was acquired in the form of absorbable surgical su-
tures under the trade name of Monocryl (Ethicon). The
solvent 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) was pur-
chased from Sigma-Aldrich (St. Louis, MO) to dissolve PCL
and PGC (weight ratio PCL:PGC = 3:1) and make a ho-
mogeneous solution. Lipase (Pseudomonas fluorescens) was
purchased from Sigma-Aldrich. The protein matrix (HB)
was provided by Vivo Biosciences Inc. (Birmingham, AL).
HUVECs and AoSMCs (Lonza Group Ltd) were kindly
provided byDr. Jun’s Laboratory at passage 3. TheHUVECs
were cultured into the endothelial cell growth media (EGM-
2 Lonza Group Ltd) at 37 C under 5 % CO2. The AoSMCs
were cultured into the smooth muscle cells growth media
(SMGM-2 Lonza Group Ltd) at 37 C under 5 % CO2.
Fabrication of electrospun tubular graft
Tubular electrospun graft was engineered by the following
method described in our recent publication (Patel et al.
2015). Briefly, PLC and PGC were mixed at a ratio of
75:25 (wt%) and a 12 % (w/v) solution was obtained. The
electrospinning technique was utilized to produce the graft.
Then, the solution was loaded into a BD 3 mL syringe with
a 25 gauge needle (Small Parts Inc). A high-voltage power
supply (M826, Gamma High-Voltage Research, Ormond
Beach, FL) was connected to the needle. The infusion rate
(1 mL/h), voltage (15 kV), and the distance between the
needle tip and the mandrel (25 cm) were used to produce
fine nano–microscale fibers. The fibers were collected onto
a 4 mm-diameter 303 stainless steel mandrel, rotating at
400 rpm. The tubular graft was removed from the mandrel
and put in a desiccator for 24 h to remove the solvent
residuals.
In vitro enzymatic degradation
To understand the lipase enzyme effect on the mechanical
properties, thegraftwas exposed to thePBSsolutionwith lipase
concentration of 2.5 lg/mL for 4 weeks. Twice a week, the
lipase solutionwas changed. Sampleswere prepared and tested
at 2 and 4 weeks’ time periods to obtain changes inmechanical
properties due to enzymatic degradation. Tensile specimens
(n = 6) were prepared by cutting the scaffolds into rectangular
stripes (3 mm 9 10 mm) in accordance with ASTM standard
D882. A dynamic mechanical analyzer with tensile fixture
(DMA, TA instruments) was used. The samples were mounted
first on the fixture. The samples were tested uniaxially using
18 N load cell at a ramp0.1 N mm-1.All values such as elastic
modulus, percent elongation to failure, and ultimate tensile
strength were obtained from stress–strain curves generated by
the TA instrument software. Further, FE-SEM (Quanta FEG
650 from FEI, Hilsboro, OR) was utilized to understand the
morphology of the vascular graft before and after enzymatic
degradation, andgraftswere cut and sputter-coatedwithAu–Pd
to understand the surfacemorphology. To obtainmass loss (%)
data, samples [1 cm 9 1 cm (n = 6)] were aged under enzy-
matic solution at 37 C for 4 weeks (Patel et al. 2015). At the
second and fourth week’s interval, the samples were removed
from the solution and placed under vacuum at room tem-
perature and the mass loss (%) was determined.
Protein matrix-coated tubular graft under in vitro
condition
The tubular graft was coated with a collagenous protein
matrix by dip coating. The tubular graft was soaked in the
PBS solution (pH7.3) overnight at 4 C towet the surface for
better collagenous protein matrix absorption. Then, the
tubular graft was dip coated by soaking in the collagenous
protein matrix with higher density (3 mg/mL) on the outside
(pH 7.3) for 2 h at 4 C. Then, the inner layer was coated
with lower density (1 mg/mL) of collagenous matrix (pH
7.3) for 2 h at 4 C. Finally, the coated graft was placed in the
incubator at 37 C in a humid environment for the gelation
and stabilization of the collagenous protein matrix for 2 h.
FT-IR and differential scanning calorimetric (DSC) tech-
niques were utilized to confirm the presence of the protein
matrix on the graft before and after aging in physiological
media. The Bruker alpha FTIR spectrometer was used with
ATR mode to acquire absorbance spectrum (64 scans per
sample, ranging from 4000 to 400 cm-1) for coated graft.
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Samples were tested by utilizing a DSC instrument (TA In-
struments Q100) from-75 to 250 C at a rate of 10 C/min.
HUVECs and AoSMCs attachment to coated graft
HUVECs and AoSMCs (Lonza Group Ltd) were kindly
provided by the Dr. Jun’s Laboratory at UAB at passage 3.
The tubular scaffolds were sterilized and preconditioned
before cell seeding by ethanol and UV sterilization. The
scaffolds were placed in 48-well plates and incubated with
100 % fetal bovine serum (FBS) (VWR international) at
37 C for 4 h (Zhang et al. 2010). Finally, the FBS was
taken out from the well. HUVECs were seeded on the
scaffold with 6 9 105 cells/cm2 density. AoSMCs were
seeded on the scaffolds with 1 9 104 cells/cm2 density.
The morphology of the HUCECs and AoSMCs was ob-
served. The scaffolds were stained with DAPI (Sigma-
Aldrich) and rhodamine phalloidin (Sigma-Aldrich) stain-
ing to stain nucleus and actin filaments respectively. Nikon
A1 confocal camera was used to acquire all the images at
409 magnification.
HUVECs attachment under laminar shear stress
The dynamic flow chamber system was set up as shown in
Fig. 7. The circular flow chamber kit was (GlycoTech Inc)
purchased. The circular flow chamber was set up by fol-
lowing the instructions provided by the manufacturer. The
silicon rubber gasket with flow width 1.00 cm and thick-
ness 0.010 inch was used. The peristaltic pump (Fisher
ScientificTM) was used to create a constant laminar flow.
The HUVECs seeded scaffold was carefully placed into the
parallel-flow chamber. The gas exchange chamber was also
placed to have proper CO2 gas exchange. The entire system
was placed in the sterilized incubator with humid condi-
tion, 37 C temperature, and proper supply of CO2. The
cell-seeded scaffolds were exposed to this laminar flow
condition for 12 h to understand the cell’s adhesion
strength (Savoji et al. 2014; Gigout et al. 2011). The flow
rate was set up to expose scaffolds to similar shear stress as
in the physiological condition (Malek et al. 1999; Dela Paz
and D’Amore 2009). The number of HUVECs retained on
the scaffold exposed to the laminar flow was compared
with non-exposed HUVECs-seeded scaffold.
Results and discussion
Our tubular graft engineered from 3:1 (PCL:PGC) by uti-
lizing an electrospinning technique was made of nano–
microscale fibers (diameter ranges from 0.5 to 1.0 lm). Its
chemical composition had a major amount of the PCL
component; hence, it was important for us to understand
the effect of the enzyme on the mechanical properties.
Therefore, we exposed the electrospun graft to the lipase-
containing PBS solution for 1 month to observe changes in
mechanical properties. The hydrolytic degradation of PCL
and PGC occurs due to the breakage of the ester bonds as
shown in the Fig. 1. The lipase enzyme also attacks these
ester bonds as shown in Fig. 1, to break the long polymer
chain into smaller oligomers which are soluble in water
(Rizzarelli et al. 2004).
The rate of the enzymatic degradation can be varied
depending on the polymer type, crystallinity, and mole-
cular weight (Nagata et al. 1998; Nikolic and Djonlagic
2001; Rizzarelli et al. 2004). Hence, the lipase enzymatic
degradation effect on the mechanical properties as well as
on morphology of the electrospun fibers were investigated
for the electrospun graft made from the PCL:PGC blend.
The specimens embedded in the lipase solution were taken
out at 2 and 4 weeks’ time points and exposed to tensile
tests. Tensile strength, Young’s modulus, and strain (%)
data were obtained. The tensile strength showed a statis-
tically significant (p\ 0.05) decrease from 1.86 ± 0.14 to
1.49 ± 0.08 MPa after 4 weeks. The ultimate tensile
strength even after 4 weeks was comparable to the human
coronary artery values as reported by Holzapfel et al.
(2005). As shown in Fig. 2b, no significant change in
Young’s modulus was noticed after 4 weeks. The elastic
modulus value after 4 weeks was found to be slightly
higher than that reported by Ozolanta et al. (1998), which
was around 4 MPa. On the other hand, the modulus of
elasticity was lower than that of the native femoral artery
(9–12 MPa) after 4 weeks’ degradation (Thomas et al.
2007). However, there was a significant (p\ 0.05) differ-
ence in strain (%) before and after exposure to the lipase
solution as shown in Fig. 2c. Figure 2d illustrates the mass
Fig. 1 Lipase effect on polycaprolactone and poliglecaprone
polymers
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loss (%) of the graft. The mass loss was increased sig-
nificantly (p\ 0.05) from 2 (3 ± 1 %) to 4 weeks
(7.3 ± 2.6 %). This mass loss (%) also helps to correlate
the decrease in tensile strength and stain (%) values. Fig-
ure 3a, b shows the electrospun fibers’ morphology before
and after enzymatic degradation. Figure 3b clearly indi-
cates the fiber brakeage due to the enzymatic degradation.
Zeng et al. (2004) reported similar fiber breaking of PLLA–
PCL based electrospun fibers.
ECM proteins coating on fibers of porous structure can
facilitate cell attachment, migration, and infiltration. To
incorporate the protein matrix, a simple dip-coating
method was utilized (Peng et al. 2010). Zhang et al. (2005)
also utilized the dip-coating method to increase surface
Fig. 2 Lipase degradation effect on mechanical properties of graft a tensile strength, b modulus of elasticity, c strain (%), and d mass loss (%)
Fig. 3 Lipase degradation
effect on the fibers’ morphology
a before and b after 4 weeks in
lipase solution
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biocompatibility of PCL non-woven scaffolds. Then, the
presence of the protein matrix was confirmed by the DSC
technique before and after aging in the media.
DSC scans of 3:1 (PCL:PGC)-coated scaffold are shown
in Fig. 4. The melting temperature of PCL was observed at
60.6 C. Schindler et al. (2013) also observed a similar
melting point for the PCL component of the PCL/polyg-
lyconate blends. Further, Lee et al. (2008b) also mentioned
a similar melting temperature (61.9 C) for the PCL elec-
trospun scaffold. The melting temperature of the PGC was
noticed at 186.8 C for 0 days. The shoulder peak at
46.7 C could be an indication of the collagen helix (Mu
et al. 2007). The shoulder around 46 C started disap-
pearing after 2 weeks and was absent at 4 weeks. This
could be the indication that at 4 weeks’ time point, the
protein matrix was not present in FTIR spectrum (Fig. 5).
The presence of N–H stretching peak at (*) 3310 cm-1
for amide A indicates the presence of protein from the
protein matrix, since the non-coated graft does not have
any amide group in the chemical structure. Further, amide I
at 1651 cm-1 corresponds to the stretching vibration of the
C=O bond. In addition, amide II at 1535 cm-1 is associated
with the vibration of C–N and N–H bonds. Amide I and II
were both present in the ATR spectrum of the protein
matrix-coated graft. Jia et al. (2013) mentioned the pres-
ence of these peaks to identify the collagen component in
the electrospun polyurethane-based scaffold. However, a
clear decrease in the N–H stretching peak at 3310 cm-1 for
amide A was noticed at 2 and 4 weeks’ time points. The
decrease in the peak intensity may indicate the disappear-
ance of the protein matrix. Similarly, the peak for amide I
at 1651 cm-1 completely disappeared at 4 weeks’ time
point. Zhang et al. (2009) also noticed a similar
disappearance of the amine I peaks after 30 days due to the
in vitro degradation of the bio-hybrid scaffold. This also
indicates that the protein matrix was washed away in the
PBS solution after 4 weeks. The data here suggest that the
bonding between the protein matrix and synthetic polymer
may be weak due to the non-covalent bonding, and cova-
lent bonding may be required for a stable attachment of the
protein matrix to the vascular graft.
One of the goals of this study was to understand the cell
attachment in static and dynamic conditions. In this study,
we seeded HUVECs on the lumen surface of the coated
graft. AoSMCs were seeded on the outer layer to under-
stand their attachment on the coated graft. In a native blood
vessel, endothelial cell which are present at a lumen
Fig. 4 DSC curves of coated
graft before and after in vitro
environment exposure
Fig. 5 FTIR spectrum indicating protein matrix eroded after 4 weeks
under in vitro condition. Proteins peaks were marked by symbols
(asterisk, hash, filled oval)
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surface experience a constant shear stress force due to
blood flow which stimulates gene expression and effects
cell metabolism as well as cell morphology (Traub and
Berk 1998). Hence, the attachment of the HUVECs on our
coated scaffolds under a shear stress environment is an
important parameter to understand. As shown in Fig. 6,
four critical components (Glyco-Tech flow chamber, a
gasket, peristaltic pump, and a gas exchange chamber)
were used. In order to calculate the flow rate to apply
physiological shear stress we used Eq. 1 as mentioned
below where Q is desired flow rate, S is the target shear
stress, l is the viscosity of the flow medium, w is width of
the flow chamber, and h is the height of the flow chamber
(Bhat et al. 1998).
Q ¼ T  w  h
2
ð6  lÞ ð1Þ
Figure 6 represents the entire closed loop system set up
to understand the HUVECs attachment under the dynamic
flow condition. Equation 1 was used to calculate the flow
rate (8 mL/min) which was able to create a shear stress
comparable to the physiological environment. Savoji et al.
(2014) has also utilized similar technique to understand the
stable endothelial spreading on the electrospun scaffolds
under the shear stress. HUVECs were exposed to this shear
stress continuously for 12 h. Then, HUVECs attachment on
coated scaffold before and after exposure to laminar shear
stress was observed by utilizing confocal microscopy. The
comparison was done by qualitative analysis. Figure 7a
represents a coated graft with HUVECs which was not
exposed to a laminar flow as a control (Peng et al. 2010).
Figure 7b represents a coated graft with AoSMCs which
was in static condition. Figure 7c illustrates the HUVECs-Fig. 6 The setup of the dynamic flow chamber in the incubator
Fig. 7 Confocal images of
scaffolds seeded with
a HUVECs and b AoSMCs.
c HUVECs attachment after
exposure to shear stress for 12 h
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seeded coated graft exposed to dynamic shear stress for
12 h. There was significantly fewer amount of cells present
after laminar flow exposure compared to the control. The
reason for fewer cells on the coated graft could be the weak
non-covalent bonding between the fibers and protein ma-
trix. Due to the weak bond, the protein matrix may have
been washed out under shear stress, leading to elimination
of the majority HUVECs. Hence, the protein matrix coat-
ing stabilization via a cross-linking agent may help a better
cell attachment under shear stress environment.
Conclusion
A small-diameter graft was engineered by utilizing the
electrospinning technique. The graft was exposed to lipase
enzymatic degradation for 1 month to understand the
changes in mechanical properties. Significant changes in
tensile strength (1.86–1.49 MPa) and strain (245–205 %)
were noticed due to enzymatic degradation. The fiber
breakage was clearly evident through scanning electron
microscopy (SEM) after 4 weeks in vitro degradation.
Further, the graft was coated with collagenous proteins and
characterized by FTIR and DSC. A preliminary dynamic
condition study to understand the HUVECs attachment was
conducted. In static condition, HUVECs and AoSMCs at-
tachment were observed. Under the dynamic flow condi-
tion, HUVECs attachment was found to be significantly
lesser compared to the control (static condition). The
weaker non-covalent bond between the protein matrix and
the graft could be the reason. Further, the protein matrix
eroded completely after 4 weeks in PBS solution, which
was confirmed by DSC and FTIR. This issue will be ad-
dressed in a future study by introducing cross-linking
agents to stabilize the protein matrix on the electrospun
fibers.
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